Colgate-Palmolive
1,474 hedge funds and large institutions have $48.9B invested in Colgate-Palmolive in 2017 Q4 according to their latest regulatory filings, with 194 funds opening new positions, 442 increasing their positions, 554 reducing their positions, and 68 closing their positions.
185% more first-time investments, than exits
New positions opened: 194 | Existing positions closed: 68
9% more funds holding
Funds holding: 1,357 → 1,474 (+117)
3% more capital invested
Capital invested by funds: $47.6B → $48.9B (+$1.32B)
0.07% less ownership
Funds ownership: 74.03% → 73.96% (-0.07%)
9% less funds holding in top 10
Funds holding in top 10: 32 → 29 (-3)
20% less repeat investments, than reductions
Existing positions increased: 442 | Existing positions reduced: 554
36% less call options, than puts
Call options by funds: $351M | Put options by funds: $546M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$258M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$149M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$107M |
| 4 |
D.E. Shaw & Co
New York
|
+$102M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
+$98.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$347M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$302M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$227M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$123M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$114M |
CL Hedge Fund Activity: Q4 2017 in Review
1,474 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q4 2017, worth a combined $48.9B — up 2.8% from $47.6B a quarter earlier.
Buyers outnumbered sellers: 194 funds opened new CL positions and 68 closed out — a net gain of 126 holders — while 442 added to existing stakes and 554 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $258M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $347M sold.
- 1,474 institutional investors held Colgate-Palmolive (CL) as of Q4 2017, up from 1,357 in Q3 2017.
- Funds reported $48.9B of Colgate-Palmolive stock for Q4 2017, up 2.8% quarter-over-quarter.
- 194 funds opened new Colgate-Palmolive positions in Q4 2017 and 68 closed out, a net change of +126 holders.
- The largest Colgate-Palmolive buyer in Q4 2017 was Morgan Stanley, an estimated $258M added.
- The largest Colgate-Palmolive seller in Q4 2017 was Baillie Gifford & Co, an estimated $347M sold.
Based on aggregated 13F filings for Q4 2017.